Evidence map›Paper›PMID 35869523›Full record

ArticleHarm reduction journal2022

The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.

Kinna Thakarar, Michael Kohut, Rebecca Hutchinson, Rebecca Bell, Hannah E Loeb, Debra Burris, Kathleen M Fairfield

Abstract read
In one paragraph

Article in Harm reduction journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Perceptions of overdose response hotlines and applications among rural and remote individuals who use drugs in Canada: a qualitative study.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024
    Article
  9. Article
  10. Frame Shift: Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kinna ThakararCenter for Interdisciplinary Population and Health Research/Maine Health Institute for Research, 509 Forest Ave, Portland, ME, USA. kinna.thakarar@mainehealth.org.
Michael KohutCenter for Interdisciplinary Population and Health Research/Maine Health Institute for Research, 509 Forest Ave, Portland, ME, USA.
Rebecca HutchinsonCenter for Interdisciplinary Population and Health Research/Maine Health Institute for Research, 509 Forest Ave, Portland, ME, USA.
Rebecca BellTufts University School of Medicine, 145 Harrison Ave, Boston, MA, USA.
Hannah E LoebTufts University School of Medicine, 145 Harrison Ave, Boston, MA, USA.
Debra BurrisCenter for Interdisciplinary Population and Health Research/Maine Health Institute for Research, 509 Forest Ave, Portland, ME, USA.
Kathleen M FairfieldCenter for Interdisciplinary Population and Health Research/Maine Health Institute for Research, 509 Forest Ave, Portland, ME, USA.

Funding

Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted InterventionsU54GM115516 · NIGMS · MAINEHEALTH · PI CLIFFORD JAMES ROSEN · 2017 to 2026
$51.6M
NIGMS NIH HHS U54 GM115516NIH HHS U54 GM115516
6 · The paper itself

Abstract

backgroundThe impact of public health policies during the COVID-19 pandemic on people who inject drugs (PWID) has varied across regions. In other countries, recent research has shown that PWID access to harm reduction services, despite rapid adaptations, has been negatively impacted. Our study describes these impacts in a rural state.

methodsWe conducted semi-structured interviews with PWID, community partners, and healthcare providers in the rural state of Maine (USA). We explored how changes made during the pandemic impacted access to harm reduction services, including basic services (i.e., shelter), syringe service programs, safe drug supply, low barrier treatment, and peer support. Interviews were analyzed using the framework method to apply Penchansky's model of access, with Saurman's modification, which includes six dimensions of access-accessibility, availability, acceptability, affordability, accommodation, awareness.

resultsWe interviewed thirty-six stakeholders (N = 9 community partners, N = 9 healthcare providers, N = 18 PWID). Policies such as mobile outreach expansion, mail delivery of equipment, and relaxed telemedicine regulations facilitated accessibility to syringe service programs and low barrier buprenorphine treatment. Public health policies, such as social distancing and screening policies, reduced contact, which subsequently reduced acceptability and awareness of many services. Elimination of the one-for-one needle exchange in some areas increased, acceptability (i.e., perception of service), and affordability for PWID. However, some areas actually began enforcing a one-for-one needle exchange policy, which reduced affordability, acceptability, and awareness of services.

conclusionsChanges resulting from the COVID-19 pandemic have impacted all dimensions of access to harm reduction services among PWID. While some barriers to harm reduction services were unavoidable during the pandemic, we found that specific policy decisions mitigated service barriers, while other policies exacerbated them. Relaxing needle exchange policies were particularly helpful in facilitating access to harm reduction services by giving community organizations flexibility to adapt to the evolving needs of PWID. These results can inform policies and service delivery to optimally mitigate the negative impacts on PWID during, and beyond, the pandemic.

Indexed as

COVID-19Drug UsersHIV InfectionsSubstance Abuse, IntravenousHarm ReductionHealth Services AccessibilityHumansNeedle-Exchange ProgramsPandemicsPharmaceutical PreparationsPharmaceutical PreparationsInjection drug useMarginalized and mobile populationsSocial and economic issues

Identifiers

PMID35869523
PMCPMC9305035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.